Northeast Bioanalytical Laboratories
UEI: N4LJNYSCCVA4
• CAGE: 4LHV1
Overview
Parent Awardee
Federal Capability Statement
NorthEast BioLab is an independent, small-business bioanalytical lab with 20+ years of experience providing bioanalysis for clinical, preclinical, and discovery studies. Our team has an excellent track record of advancing pharmacokinetics, toxicology, immunogenicity, cytokine, bioequivalence, pharmacodynamics biomarker, and custom bioanalytical assays. We offer method development and validation using Ligand Binding Assays (ELISA, Meso Scale Discovery, Luminex, Western Blotting, etc.), Mass Spectrometry Liquid Chromatography (LC-MS/MS, HPLC-UV/DAD/Fluorescence, etc.), and Cell And Gene Therapy platforms (Cell-Based Assay, qPCR and Digital dPCR). We are a full-service, GLP/GCLP compliant, FDA audited, and DEA & CT State Schedule II-IV approved, Watson LIMS enabled facility. One of the ways we differentiate ourselves is through our fast turnaround with high quality at competitive pricing. Contact us now to accelerate your bioanalytical assay development, validation, and sample analysis!
Keywords
Ada, assay development, method validation, bioanalysis, bioanalytical, cell based assay, copy number, cro, cytokine, digital pcr dpcr ddpcr, elisa, gene expression, hplc, immunogenicity, lc ms, mass spectrometry, meso scale discovery, msd, nab, pharmacokinetic, pk pd, qpcr, sample analysis, western blot, uplc
SBA Special Equipment
LC-MS assay and LC-MS/MS analysis, Mass Spectrometry Services, and HPLC Lab need for various types of therapeutics, including small molecules, peptides, mAbs, oligonucleotides, and more. LC-MS method development and validation and LC-MS quantitation on triple quad AB Sciex equipment.
Meso Scale Discovery (MSD) And ELISA Assay Validation for PK/PD, ADA/NAb, Cytokine Multiplex Analysis, and Titration. Reproducible Sandwich, Competitive, Indirect MSD Or ELISA Testing Services Lab. Rapid ELISA Assay Development & GLP ELISA Assay Validation for Biologics, Vaccines, Biomarkers, Viral Titers. FDA Audited Preclinical/Clinical ELISA Immunoassay Services - Absorbance, Meso Scale, Luminescence, Fluorescence, TR-FRET, AlphaLISA. Tailor-Made, High-Value ELISA Lab Services using Proprietary/Commercial Antibodies and Research Use Kits for 1,000+ Analytes.
qPCR and Digital dPCR assay services for gene expression, biodistribution, viral shedding, CNV assays, residual Host Cell DNA testing, etc.
Website
Headquarters
Hamden, CT
United States
United States
Most Recent Award
Aug. 20, 2025
Calculating
Federal contract recipient
NORTHEAST BIOANALYTICAL LABORATORIES LLC
(UEI N4LJNYSCCVA4, CAGE 4LHV1)
is headquartered in Hamden CT.
Its primary registered NAICS is 541380 Testing Laboratories and Services.
The partnership
was founded in January 2003 and
federally registered in
November 2006.
About
Mission Statement
With over 20 years of expertise, NorthEast BioAnalytical Laboratories LLC, also known as NorthEast BioLab, specializes in providing top-notch GLP and clinical bioanalytical services. We are proud to be trusted partners to hundreds of industry sponsors and renowned investigators in the biotechnology sector.
We are an independent, full-service facility that adheres to GLP/GCLP compliance. Our FDA-audited and DEA & CT State Schedule II-IV approved facility is managed by Watson LIMS, ensuring seamless operations. Our dedicated scientists and project teams excel in assay development, optimization, troubleshooting, and full method validation on various platforms, including Ligand Binding Assays (ELISA, Meso Scale Discovery, Luminex, Western Blotting, etc.), Mass Spectrometry Liquid Chromatography (LC-MS/MS, HPLC-UV/DAD/Fluorescence, etc.), and Cell And Gene Therapy platforms (Cell-Based Assay, qPCR and dPCR).
With our custom assay development services, we offer comprehensive solutions for pharmacokinetics analysis studies, toxicokinetic safety testing, immunogenicity assay, multiplex cytokine analysis, PD biomarker assessment, biochemical assay, mechanism of action, gene expression, copy number variation investigations, etc.
Since its establishment in 2003, our team of dedicated biologists and chemists has been committed to empowering mission-driven biotech and government agencies.
SPEAK TO OUR SCIENTISTS today to expedite your bioanalytical assay and analysis.
We are an independent, full-service facility that adheres to GLP/GCLP compliance. Our FDA-audited and DEA & CT State Schedule II-IV approved facility is managed by Watson LIMS, ensuring seamless operations. Our dedicated scientists and project teams excel in assay development, optimization, troubleshooting, and full method validation on various platforms, including Ligand Binding Assays (ELISA, Meso Scale Discovery, Luminex, Western Blotting, etc.), Mass Spectrometry Liquid Chromatography (LC-MS/MS, HPLC-UV/DAD/Fluorescence, etc.), and Cell And Gene Therapy platforms (Cell-Based Assay, qPCR and dPCR).
With our custom assay development services, we offer comprehensive solutions for pharmacokinetics analysis studies, toxicokinetic safety testing, immunogenicity assay, multiplex cytokine analysis, PD biomarker assessment, biochemical assay, mechanism of action, gene expression, copy number variation investigations, etc.
Since its establishment in 2003, our team of dedicated biologists and chemists has been committed to empowering mission-driven biotech and government agencies.
SPEAK TO OUR SCIENTISTS today to expedite your bioanalytical assay and analysis.
Preferred Contact
Teaming Goals
Prime Opportunities
Sub Opportunities
Sub Opportunities
Federal Award Analysis
Northeast Bioanalytical Laboratories federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NORTHEAST BIOANALYTICAL LABORATORIES LLC
UEI
N4LJNYSCCVA4
CAGE Code
4LHV1
Primary NAICS
SBA Certifications
None
Self Certifications
Minority Owned Business
Subcontinent Asian (Asian-Indian) American Owned
Subcontinent Asian (Asian-Indian) American Owned
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 11, 2003
Initial Registration
Nov. 17, 2006
Last Registration
Oct. 10, 2025
Registration Activation
Oct. 14, 2024
Registration Expiration
Oct. 10, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
CT
Country of Incorporation
USA
Employees
<500
Disaster Registry
Specific Regions
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes